Clinical Trial: A Phase III Clinical Trial Evaluating SR604 Injection for Prophylactic Treatment in Patients With Hemophilia

U.S., Oct. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07876674) titled 'A Phase III Clinical Trial Evaluating SR604 Injection for Prophylactic Treatment in Patients With Hemophilia' on Oct. 09.

Brief Summary: This is a single-arm, multicenter Phase III clinical trial designed to evaluate the efficacy and safety of prophylactic treatment with SR604 Injection in hemophilia A/B patients with or without inhibitors.

Study Start Date: Sept. 30

Study Type: INTERVENTIONAL

Condition: Hemophilia A Hemophilia A and B Hemophilia B

Intervention: DRUG: SR604

SR604 will be administered as SC injection.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Shanghai RAAS Blood Products Co., Ltd.

Disclaimer: Curated ...